Robbins Arroyo LLP Is Investigating the Directors and Officers of Sequenom, Inc. on Behalf of Shareholders

 Robbins Arroyo LLP Is Investigating the Directors and Officers of Sequenom,
                        Inc. on Behalf of Shareholders

PR Newswire

SAN DIEGO, Sept. 9, 2013

SAN DIEGO, Sept. 9, 2013 /PRNewswire/ --Shareholder rights law firm Robbins
Arroyo LLP is investigating whether certain officers and directors of
Sequenom, Inc. (NASDAQ: SQNM) breached their fiduciary duties to
shareholders. Sequenom provides genetic analysis solutions in the United
States and internationally.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO)

Sequenom Stock Drops on Report of Cash Collection Problems

On July 24, 2013, Sequenom announced the company's financial results for the
second quarter of 2013. Despite reporting a 91% increase in total revenues to
$34.9 million for the quarter, Sequenom also reported a net loss of $31
million, as compared to a net loss of $29.6 million for the same period in
2012. According to Sequenom, the company suffered from delays in collecting
payments as a result of medical coding changes adopted by Medicare, Medicaid,
and other third-party payors. Sequenom also revealed that certain payors,
including most state Medicaid plans, have yet to implement the new codes and,
in some cases, no longer provide coverage for certain tests. On this news,
Sequenom's share price fell $1.39 per share, or 30%, to close at $3.30 on July
25, 2013.

Robbins Arroyo LLP highlights that Sequenom shareholders have the option to
pursue a shareholder derivative action through which shareholders aim to hold
insider wrongdoers accountable for their actions, prevent future misconduct,
and bring long-term value back to the company. Concerned shareholders who
would like more information about their rights and potential remedies can
contact attorney Darnell R. Donahue at (800) 350-6003,
DDonahue@robbinsarroyo.com, or via the shareholder information form on the
firm's website.

Robbins Arroyo LLP is a nationally recognized leader in securities litigation
and shareholder rights law. The firm represents individual and institutional
investors in shareholder derivative and securities class action lawsuits, and
has helped its clients realize more than $1 billion of value for themselves
and the companies in which they have invested. For more information, please
go to http://www.robbinsarroyo.com.

Press release link:
http://www.robbinsarroyo.com/shareholders-rights-blog/sequenom-inc/

Attorney Advertising.Past results do not guarantee a similar outcome.

Contact:
Darnell R. Donahue
Robbins Arroyo LLP
DDonahue@robbinsarroyo.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsarroyo.com

SOURCE Robbins Arroyo LLP

Website: http://robbinsumeda.com